Renata Moll‐Bernardes

Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19

Renato D. Lópes, Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva et al. · JAMA · 2021 · 374 citations · Full text

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

Renato D. Lópes, Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva et al. · American Heart Journal · 2020 · 144 citations · Full text

Antiviral Therapy, Brace Corona Trial, Acute Myocardial Infarction +5

Sympathetic Neural Overdrive, Aortic Stiffening, Endothelial Dysfunction, and Impaired Exercise Capacity in Severe COVID-19 Survivors: A Mid-Term Study of Cardiovascular Sequelae

Diego Faria, Renata Moll‐Bernardes, Laura Testa et al. · Hypertension · 2022 · 40 citations · Full text

IL-10 and IL-12 (P70) Levels Predict the Risk of Covid-19 Progression in Hypertensive Patients: Insights From the BRACE-CORONA Trial

Renata Moll‐Bernardes, Andréa Silvestre de Sousa, Ariane Vieira Scarlatelli Macedo et al. · Frontiers in Cardiovascular Medicine · 2021 · 34 citations · Full text

Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial

Ariane Vieira Scarlatelli Macedo, Pedro Gabriel Melo de Barros e Silva, Thiago Ceccatto de Paula et al. · American Heart Journal · 2022 · 19 citations · Full text

Thrombosis, Long Covid, Cardiovascular Disease +11